Letermovir for CMV Prevention After Lung Transplantation

Clinical trial NCT05041426 · COMPLETED

Trial details

NCT number: NCT05041426
Sponsor: Fernanda P Silveira, MD, MS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Transplant CMV

Start date: 2021-12-06
Primary completion: 2025-03-03
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.